News and Announcements
Matsa (ASX: MAT) announces commencement of mining at Red Dog Gold Mine
- Published September 10, 2018 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
KEY TAKEAWAYS:
- Matsa Resources Limited (ASX: MAT) has announced that mining has commenced at the Red Dog Gold Mine.
- The first blast hole drilling is currently underway.
- All gold ore will be treated at AGAA’s Sunrise Dam Gold Mine (SDGM) treatment facilities as per the current agreement.
Matsa Resources Limited (ASX: MAT) has announced that mining has commenced at the Red Dog Gold Mine. The mine lies approximately 25km west of Matsa’s Fortitude Gold Mine, 16km south-west of the Red October Gold Mine and 7km west of Second Fortune Gold Mine.
All gold ore will be treated at AGAA’s Sunrise Dam Gold Mine (SDGM) treatment facilities as per the agreement with AngloGold Ashanti Australia Limited (AGAA).
All equipment and offices have been set up on site with the first blast hole drilling currently underway.
About Matsa Resources Limited (ASX: MAT)
Matsa is an ASX listed explorer/developer who has become a gold producer following the acquisition and development of the Fortitude gold mine. Fortitude forms part of the Lake Carey gold project south of Laverton. Matsa has a pipeline of quality projects within Australia and central Thailand. Matsa has recently acquired the Red October Gold mine near Lake Carey which boosts the mining potential within the area.
Company Updates
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be Attracting Big Pharma’s Attention
Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
Backed By Leading Investment Groups and Family Offices
